Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Irritable Bowel Syndrome, December 2025 Free Subscription Abstracts Retrieve all available abstracts of the following 91 articles: HTML format

Single Articles

1. LONG Q, Li L, Tan Z, Deng N, et al
   Sishen Pill treats spleen-kidney yang deficiency IBS-D by influencing ATPase activity and intestinal microbiota.
   Front Microbiol. 2025;16:1610928.
   PubMed    
   Abstract available
   
   

2. PENNANEACH C, Bonham MP, Kelly T, Gibson R, et al
   High prevalence of disorders of irritable bowel syndrome and functional dyspepsia in night shift workers: a cross-sectional study in Australia and the UK.
   Clin Gastroenterol Hepatol. 2025 Nov 25:S1542-3565(25)01003.
   PubMed    
   Abstract available
   
   

3. JIA J, Wang M, Shi Y, Yang C, et al
   Sleep health as a mediator between depression and functional gastrointestinal disorders: A UK Biobank study.
   J Affect Disord. 2025 Nov 25:120768. doi: 10.1016/j.jad.2025.120768.
   PubMed    
   Abstract available
   
   

4. AGGELETOPOULOU I, Karaivazoglou K, Kalafateli M, Triantos C, et al
   Targeting Irritable Bowel Syndrome Through Diet and Mechanism-Based Therapies: A Pathophysiological Approach.
   Nutrients. 2025;17:3595.
   PubMed    
   Abstract available
   
   

5. DALE HF, Kolby M, Valeur J
   Ultra-Processed Food Consumption and Irritable Bowel Syndrome: Current Evidence and Clinical Implications.
   Nutrients. 2025;17:3567.
   PubMed    
   Abstract available
   
   

6. RUDEN DM
   The Human Archaeome: Commensals, Opportunists, or Emerging Pathogens?
   Pathogens. 2025;14:1111.
   PubMed    
   Abstract available
   
   

7. MAIMARIS S, Scarcella C, Memoli GA, Crisciotti C, et al
   Non-Coeliac Wheat Sensitivity: Symptoms in Search of a Mechanism, or a Distinct Well-Defined Clinical Entity? A Narrative Review.
   Int J Mol Sci. 2025;26:11174.
   PubMed    
   Abstract available
   
   

8. GIGANTE G, Gostoli S, Dettori C, Montecchiarini M, et al
   Psychosomatic Profiles and Their Association with Health Behaviors in Patients with Inflammatory Bowel Disease (IBD) and Low Disease Activity.
   J Clin Med. 2025;14:7944.
   PubMed    
   Abstract available
   
   

9. ARAI T, Hirose M, Kagawa T, Takeuchi N, et al
   Effectiveness of a 5-Hydroxytryptamine Type 3 Receptor Antagonist for Treating Nintedanib-Induced Diarrhea: A Prospective Observational Study.
   J Clin Med. 2025;14:7914.
   PubMed    
   Abstract available
   
   

10. KARIMI FOROOD AM, Pandian SM, McNaboe RQ, De Carvalho Lachos T, et al
    Development and Validation of a Multimodal Wearable Belt for Abdominal Biosignal Monitoring with Application to Irritable Bowel Syndrome.
    Micromachines (Basel). 2025;16:1255.
    PubMed    
    Abstract available
    
    

11. YERRAPRAGADA G, Lee J, Shariff MN, Elangovan P, et al
    A Novel Unsupervised You Only Listen Once (YOLO) Machine Learning Platform for Automatic Detection and Characterization of Prominent Bowel Sounds Towards Precision Medicine.
    Bioengineering (Basel). 2025;12:1271.
    PubMed    
    Abstract available
    
    

12. KESAVAN C, Strong DD, Strong RM
    Correction of Vitamin D Deficiency Improves PTSD Symptoms in Gulf War Veterans.
    Brain Sci. 2025;15:1135.
    PubMed    
    Abstract available
    
    

13. ZHAO SJ, Wang TT, Zhang Q, Akerman S, et al
    The role of stress in the comorbidity of migraine and other chronic primary pain.
    Headache. 2025 Nov 26. doi: 10.1111/head.70004.
    PubMed    
    Abstract available
    
    

14. BARBEK R, Makowski AC, von dem Knesebeck O
    Social inequalities, psychosocial influences, and symptom development in patients with irritable bowel syndrome - a longitudinal qualitative analysis of the SOMA.SOC study.
    BMC Public Health. 2025 Nov 26. doi: 10.1186/s12889-025-25628.
    PubMed    
    Abstract available
    
    

15. YESHITILA ET, Aliye NJ, Mohammed Nur A, Yilma M, et al
    Prevalence and associated factors of irritable bowel syndrome among medical students in Ethiopia: a cross-sectional study.
    BMC Gastroenterol. 2025 Nov 26. doi: 10.1186/s12876-025-04415.
    PubMed    
    Abstract available
    
    

16. CAGIL EM, Yakhshilikova L, Ersoz M
    Smart bioconjugated MOFs for targeted drug delivery: Albumin and globulin effects on mebeverine release dynamics.
    Nanomedicine. 2025;71:102882.
    PubMed    
    Abstract available
    
    

17. GUO X, Cheng T, Xuan M, Li G, et al
    Huoxiang Zhengqi oral liquid for irritable bowel syndrome with diarrhea: a multicenter, double-blind, randomized controlled trial.
    Phytomedicine. 2025;149:157567.
    PubMed    
    Abstract available
    
    

18. RETTURA F, Lambiase C, Bottari A, Filippini F, et al
    Gut Virome: What's the Role in Irritable Bowel Syndrome?
    Rev Med Virol. 2025;35:e70080.
    PubMed    
    Abstract available
    
    

19. WU J, Liu Z, Liu L, Liu Q, et al
    Association Between Irritable Bowel Syndrome and Hypothyroidism: Insights from Large-Scale Population-Based Studies.
    Endocr Metab Immune Disord Drug Targets. 2025.
    PubMed    
    Abstract available
    
    

20. WANG Q, Meng Q, Chen Y, Liu Y, et al
    Interaction between gut microbiota and immunity in health and intestinal disease.
    Front Immunol. 2025;16:1673852.
    PubMed    
    Abstract available
    
    

21. KOTANI S, Mishima Y, Kishimoto K, Oka A, et al
    Association between Toll-like receptor 9 signaling defect and developing post-infectious irritable bowel syndrome.
    Front Immunol. 2025;16:1672117.
    PubMed    
    Abstract available
    
    

22. DU L, Cheng F, Shen W, Zhu Y, et al
    Microbial dysbiosis-associated NMDAR hyperfunction in post-infectious irritable bowel syndrome with visceral hypersensitivity.
    Gastroenterol Rep (Oxf). 2025;13:goaf065.
    PubMed    
    Abstract available
    
    

23. BINOD M, Chang L, Hung MW, Dong TS, et al
    Multi-omics analysis reveal clinical-gut-brain interactions in female ibs patients with adverse childhood experiences.
    Biol Sex Differ. 2025;16:101.
    PubMed    
    Abstract available
    
    

24. CHEN J, Li A, Wu W, Xu W, et al
    Machine learning to phenotype pain and predict response to pain interventions among young adults with irritable bowel syndrome.
    medRxiv [Preprint]. 2025 Oct 8:2025.10.07.25337516.
    PubMed    
    Abstract available
    
    

25. LIU Y, Li M, Lian X, Chen X, et al
    Mesenchymal stem cells' exosomes alleviate chronic visceral pain through Nrf-2-mediated oxidative stress pathway in rats.
    Pain Rep. 2025;10:e1372.
    PubMed    
    Abstract available
    
    

26. LI X, Yuan Q, Huang H, Wang L, et al
    Gut microbiota in irritable bowel syndrome: a narrative review of mechanisms and microbiome-based therapies.
    Front Immunol. 2025;16:1695321.
    PubMed    
    Abstract available
    
    

27. JENSEN LG, Kjaer M, Andersen JR
    Modification of the Low FODMAP Diet Is Feasible in the Treatment of Irritable Bowel Syndrome: A Randomised Crossover Study.
    Gastroenterol Res Pract. 2025;2025:4152978.
    PubMed    
    Abstract available
    
    

28. SUN YS, Bai XQ, Sun KD, Li J, et al
    Thymosin beta4 released by mast cells under stress conditions impairs intestinal epithelial barrier via IL22RA1/JAK1/STAT3 signaling in irritable bowel syndrome.
    World J Gastroenterol. 2025;31:111706.
    PubMed    
    Abstract available
    
    

29. MOU J, Tao Q, Xu L, Luo Y, et al
    Diagnostic accuracy of biomarkers for irritable bowel syndrome: a systematic review and meta-analysis.
    Clin Biochem. 2025;141:111061.
    PubMed    
    Abstract available
    
    

30. DUBERG A, Eriksson M, Philipson A
    Parent-child agreement in reporting somatic distress, gastrointestinal symptoms, mental health, and general health in girls with functional abdominal pain.
    Eur J Pediatr. 2025;184:780.
    PubMed    
    Abstract available
    
    

31. SCHAAB SN, Gutierrez MC
    [Emerging Nutritional Interventions for Irritable Bowel Syndrome: Starch- and Sucrose-Reduced Diet and Mediterranean Diet].
    Acta Gastroenterol Latinoam. 2025;55:103-111.
    PubMed    
    Abstract available
    
    

32. LUO Y, Xu Z, Li R, Zhang Q, et al
    Impact of low-FODMAP diet on symptom relief in irritable bowel syndrome patients.
    Asia Pac J Clin Nutr. 2025;34:905-912.
    PubMed    
    Abstract available
    
    

33. KURTULUS D, Arkan K, Suceken FY, Akgol S, et al
    Assessment of Overactive Bladder in Women With Fibromyalgia Presenting With Lower Urinary Tract Symptoms: A Controlled Clinical Study.
    Neurourol Urodyn. 2025 Dec 3. doi: 10.1002/nau.70206.
    PubMed    
    Abstract available
    
    

34. ALQARNI F, Kumasaka S, Hoad CL, Wilkinson-Smith V, et al
    Length of the Adult Human Colon in Health and Constipation Measured Using Magnetic Resonance Imaging.
    Neurogastroenterol Motil. 2025 Dec 2:e70215. doi: 10.1111/nmo.70215.
    PubMed    
    Abstract available
    
    

35. YU H, Zhang Y, Yang D, Luo H, et al
    Advances in capsule-based fecal microbiota transplantation: clinical applications and innovations.
    J Transl Med. 2025;23:1370.
    PubMed    
    Abstract available
    
    

36. VAN VORSTENBOSCH R, Skawinski M, Jonkers DMAE, Elizalde Vilalta M, et al
    Irritable Bowel Syndrome-specific Volatile Organic Compounds in Faecal Headspace do not associate with classical symptom-based subtypes.
    J Breath Res. 2025 Dec 2. doi: 10.1088/1752-7163.
    PubMed    
    Abstract available
    
    

37. GUPTA N, Ray M, Shayya A, McGinnis S, et al
    Isotretinoin Does Not Increase the Risk of Inflammatory Bowel Disease: A TriNetX Retrospective Cohort Analysis.
    J Drugs Dermatol. 2025;24:1168-1172.
    PubMed    
    Abstract available
    
    

38. MO JH, Zeng P, Zhou LL, Xia BQ, et al
    Outcome measures for irritable bowel syndrome: a scoping review.
    BMC Med Res Methodol. 2025 Dec 1. doi: 10.1186/s12874-025-02718.
    PubMed    
    Abstract available
    
    

39. STAUDACHER HM, So D, Hockey M, Mahoney S, et al
    Adherence to a Mediterranean diet predicts gastrointestinal and anxiety symptom response in irritable bowel syndrome.
    Clin Gastroenterol Hepatol. 2025 Nov 29:S1542-3565(25)01010.
    PubMed    
    
    
    

40. ZHANG Y, Walker RW, Kaplan RC, Qi Q, et al
    Added sugars, gut microbiota, and host health.
    Gut Microbes. 2025;17:2592431.
    PubMed    
    Abstract available
    
    

41. BEEREN FMM, Roosenboom B, Spanier MBW, Groenen MJM, et al
    Fecal Calprotectin Levels in Post-Metabolic Bariatric Surgery Patients: A Retrospective Study.
    Inflamm Intest Dis. 2025;10:329-336.
    PubMed    
    Abstract available
    
    

42. HENEBERG P
    Commensal, pathogen, or passenger? Rethinking the role of Blastocystis in human health.
    One Health. 2025;21:101272.
    PubMed    
    Abstract available
    
    

43. BRIZUELA M, Bony AR, Garcia-Caraballo S, Adams DJ, et al
    GABA(B) receptor-mediated modulation of sensory neuron excitability: Roles of Ca(V)2.2, G-protein-coupled inwardly rectifying potassium (GIRK) channels, and hyperpolarisation-activated cyclic nucleotide-gated (HCN) channels in human and mouse nocicept
    Exp Physiol. 2025 Nov 30. doi: 10.1113/EP093318.
    PubMed    
    Abstract available
    
    

44. LAMBIASE C, Usai Satta P, Bassotti G, Giacomelli L, et al
    Iberogast in functional dyspepsia: yesterday, today, and tomorrow - a narrative review of a multitarget phytomedicine.
    Expert Opin Pharmacother. 2025 Nov 30. doi: 10.1080/14656566.2025.2597281.
    PubMed    
    Abstract available
    
    

45. SOETAERT C, Itani M, Triadafilopoulos G, Spencer S, et al
    Evacuation Dysfunction Does Not Impact Breath Test Results.
    Neurogastroenterol Motil. 2025 Dec 12:e70211. doi: 10.1111/nmo.70211.
    PubMed    
    Abstract available
    
    

46. SOMI MH, Faghieh Dinavari M, Sajedi B, Rasooli Manesh SM, et al
    Mesalazine vs. IBS-D: Examining its impact on patient symptoms & stool calprotectin levels: A randomized double-blind, placebo-controlled trial.
    Caspian J Intern Med. 2025;16:667-673.
    PubMed    
    Abstract available
    
    

47. ZALZMAN M, Banerjee A
    Herbal formulas and gastrointestinal motility: Bridging traditional medicine and mechanistic insights.
    World J Gastroenterol. 2025;31:113332.
    PubMed    
    Abstract available
    
    

48. AGRAWAL H, Agarwal N, Gupta N
    Enteric nervous system as a therapeutic target in gastrointestinal disorders.
    World J Gastrointest Pharmacol Ther. 2025;16:110843.
    PubMed    
    Abstract available
    
    

49. CAPRA ME, Sguerso T, Aliverti V, Pisseri G, et al
    Gluten-related nutritional challenges in pediatric subjects: treatment and beyond.
    Front Nutr. 2025;12:1709121.
    PubMed    
    Abstract available
    
    

50. KAYALI S, Marabotto E, Bodini G, Marenco S, et al
    Stress, Diet, and Sleep Shape Irritable-Bowel-Syndrome-Specific Symptoms: The Lockdown "Cocoon Effect".
    J Clin Med. 2025;14:8487.
    PubMed    
    Abstract available
    
    

51. AGBOR TA, Khan WI
    Recent Trend of Laboratory Tests in Common Gastrointestinal Tract Disorders.
    Diagnostics (Basel). 2025;15:2998.
    PubMed    
    Abstract available
    
    

52. KNESS L, Quick V
    Exploring Maladaptive Eating Behaviors and Quality of Life in Those with Bowel Diseases.
    Nutrients. 2025;17:3738.
    PubMed    
    Abstract available
    
    

53. LI M, Ng CYJ, Chen H, Lam WC, et al
    Polysaccharides from Atractylodes macrocephala: A Review of Mechanistic and Therapeutic Insights into Intestinal Disorders.
    Nutrients. 2025;17:3722.
    PubMed    
    Abstract available
    
    

54. KIM Y, Kim D, Jin H, Ahn E, et al
    Depression Among Individuals with Irritable Bowel Syndrome: A Nationwide Claims-Based Analysis of 3.9 Million Koreans.
    Healthcare (Basel). 2025;13:2998.
    PubMed    
    Abstract available
    
    

55. GAO F, Chen X, Liu Z, Fan Y, et al
    Regulatory Roles of Noncoding RNAs in Visceral Hypersensitivity in Irritable Bowel Syndrome.
    FASEB J. 2025;39:e71327.
    PubMed    
    Abstract available
    
    

56. NOGUEIRA NETO J, Veigas KIS, Gomes LMRS, Barros RAJPA, et al
    Irritable bowel syndrome and chronic pelvic pain: a systematic review and meta-analysis.
    Rev Assoc Med Bras (1992). 2025;71:e20250758.
    PubMed    
    
    
    

57. KWIECIEN S, Sliwowski Z, Pajdo R, Ptak-Belowska A, et al
    Role of brain-gut axis in mechanism of gastrointestinal defense.
    J Physiol Pharmacol. 2025;76:487-499.
    PubMed    
    Abstract available
    
    

58. SHANG T, Zhang R, Liu Y, Shi S, et al
    Intestinal oxygen and microbiota crosstalk: implications for pathogenesis of gastrointestinal diseases and emerging therapeutic strategies.
    Gut Pathog. 2025;17:100.
    PubMed    
    Abstract available
    
    

59. KE S, Chen Z, Qi Y, Zhang J, et al
    Heyndrickxia coagulans as a next-generation probiotic: current evidence and future perspectives.
    Food Funct. 2025 Dec 8. doi: 10.1039/d5fo03559.
    PubMed    
    Abstract available
    
    

60. LIU LD, Duricka DL
    Case Report: Celiac plexus block improves gastrointestinal Long COVID symptoms.
    Front Neurosci. 2025;19:1589809.
    PubMed    
    Abstract available
    
    

61. SARKAR D, Roy P, Saha S
    Meta-analysis of faecal microbiome studies followed by machine learning to identify intestinal disease-specific taxonomic signatures.
    Microb Pathog. 2025 Dec 5:108221. doi: 10.1016/j.micpath.2025.108221.
    PubMed    
    Abstract available
    
    

62. GROEN SR, Keszthelyi D, Weerts ZZRM, Snijkers JTW, et al
    Psychological factors: the defining features of quality of life in disorders of gut-brain interaction - a comparative exploratory analysis.
    Clin Gastroenterol Hepatol. 2025 Dec 5:S1542-3565(25)01009.
    PubMed    
    Abstract available
    
    

63. LI Q, Zhou L, Chen G, Zhao X, et al
    Chinese medicine (Tiao-Chang Ke-Min granules) placebo and nocebo effects for diarrhea-predominant irritable bowel syndrome: a study protocol for a randomized controlled trial based on a balanced experimental design.
    BMC Complement Med Ther. 2025 Dec 6. doi: 10.1186/s12906-025-05205.
    PubMed    
    Abstract available
    
    

64. SHOKRANI A, Seck A, Feng B, Pierce DM, et al
    Methods for quantitative analyses of nerve fiber deformation in the myenteric plexus under loading of mouse distal colon and rectum.
    Med Eng Phys. 2025;146:104444.
    PubMed    
    Abstract available
    
    

65. XING T, Ozkaya KS, Nassrallah Z, Travagli RA, et al
    The Vagus Connection: Exploring the Neurobiology of Brain-Gut Communication.
    J Neurophysiol. 2025 Dec 5. doi: 10.1152/jn.00516.2024.
    PubMed    
    Abstract available
    
    

66. HOU YJ, Zheng HB, Wang K, Jiang HL, et al
    Electroacupuncture repairs intestinal mucosal barrier in rats with diarrhea-predominant irritable bowel syndrome by regulating adherens junctions through mast cells and microRNAs.
    J Integr Med. 2025 Nov 14:S2095-4964(25)00175-X. doi: 10.1016/j.joim.2025.
    PubMed    
    Abstract available
    
    

67. MAUROTTI S, Ferro Y, Mazza E, Tirinato L, et al
    Ancient grain flour consumption as a novel therapeutic approach for irritable bowel syndrome.
    Eur J Nutr. 2025;65:11.
    PubMed    
    Abstract available
    
    

68. WANG Z, Xu H, Liu Z
    Oral paroxetine improves symptoms and quality of life in refractory irritable bowel syndrome: a retrospective study.
    Am J Transl Res. 2025;17:8525-8535.
    PubMed    
    Abstract available
    
    

69. HAO YB, Liu YL, Wang XM, Cheng K, et al
    Effects of Electroacupuncture at ST36 on Visceral Pain and Inflammatory Markers in IBS Rats.
    Neurogastroenterol Motil. 2025 Dec 18:e70195. doi: 10.1111/nmo.70195.
    PubMed    
    Abstract available
    
    

70. WANG L, Chang X, Zhang L, Xu R, et al
    Revealing the Immune and Inflammatory Mechanisms of Electroacupuncture in Male IBS Rats Through Multi-Omics Analysis.
    Neurogastroenterol Motil. 2025 Dec 18:e70185. doi: 10.1111/nmo.70185.
    PubMed    
    Abstract available
    
    

71. VENKATARAMAN A, Figueroa EE, Castro J, Navarro FC, et al
    A cellular basis for heightened gut sensitivity in females.
    Science. 2025;390:1285-1291.
    PubMed    
    Abstract available
    
    

72. CHEN T, Liao F, Li L, Li K, et al
    Quality assessment of irritable bowel syndrome-related medical information on major video platforms in China: a cross-sectional study.
    BMJ Open. 2025;15:e093666.
    PubMed    
    Abstract available
    
    

73. BALDASSAR L, Cendron L, Facchin S, Redavid C, et al
    Protease profiling in fecal samples: a novel non-invasive diagnostic tool for gastrointestinal disorders.
    Sci Rep. 2025 Dec 17. doi: 10.1038/s41598-025-32301.
    PubMed    
    Abstract available
    
    

74. MOGI K, Morimoto H, Yasukawa T, Uozumi Y, et al
    Effect of PEGylated Liposomalization of Oxaliplatin on the Gut Microbiota in Mice.
    Biol Pharm Bull. 2025;48:1932-1939.
    PubMed    
    Abstract available
    
    

75. HOGUE C, Laforce S, Tremblay M, Mukaneza Y, et al
    An online low-FODMAP educational intervention improves physical and psychological symptoms of irritable bowel syndrome.
    Appl Physiol Nutr Metab. 2025 Dec 17. doi: 10.1139/apnm-2025-0288.
    PubMed    
    Abstract available
    
    

76. LINAS I, Vavricka SR, Langhorst J, Pohl D, et al
    Treatment of disorders of gut-brain interaction with peppermint oil and caraway oil combination Menthacarin : A phase IV clinical trial.
    Wien Med Wochenschr. 2025 Dec 17. doi: 10.1007/s10354-025-01119.
    PubMed    
    Abstract available
    
    

77. MAEHDER K, Peters L, Hubener S, Matysiak A, et al
    Efficacy of a mechanism-based psychological intervention for persistent gastrointestinal symptoms in ulcerative colitis and irritable bowel syndrome: results of a three-arm randomised controlled trial (SOMA.GUT-RCT).
    EClinicalMedicine. 2025;90:103663.
    PubMed    
    Abstract available
    
    

78. FERRIS MM, Subitoni Antonio L, Al-Sadi R
    Probiotics and the intestinal tight junction barrier function.
    Front Cell Dev Biol. 2025;13:1671152.
    PubMed    
    Abstract available
    
    

79. GUPTA P, Debnath B, Ashique S, Ramzan M, et al
    The melatonin-microbiome axis: a new frontier in gut health for the immunomodulatory, antioxidant and anti-inflammatory properties.
    Inflammopharmacology. 2025 Dec 17. doi: 10.1007/s10787-025-02005.
    PubMed    
    Abstract available
    
    

80. MUSHAK SCAPITAL EM, CYRILLIC, Sirchak SS, Vaynahiy OM, Balazh OP, et al
    Level of cholecystokinin after cholecystectomy in patients with irritable bowel syndrome and obesity.
    Wiad Lek. 2025;78:2063-2067.
    PubMed    
    Abstract available
    
    

81. ALMOGBEL E, A Al-Harbi F, Alamro AM, Al-Saif AK, et al
    Efficacy of hypnotherapy in the treatment of irritable bowel syndrome (IBS): a systematic review and meta-analysis.
    Am J Clin Hypn. 2025 Dec 16:1-15. doi: 10.1080/00029157.2025.2585911.
    PubMed    
    Abstract available
    
    

82. BHEEMANENI RS, Sakarkar P, Nigam A, Nwachukwu EC, et al
    Unraveling the Association Between Fibromyalgia and Irritable Bowel Syndrome: A Systematic Review.
    Cureus. 2025;17:e96801.
    PubMed    
    Abstract available
    
    

83. SUKKAR GA, Kordi RE, Alahmadi RY
    A Cross-Sectional Study on Pediatric Resident Knowledge and Perceptions of Irritable Bowel Syndrome and Inflammatory Bowel Disease in Western Saudi Arabia.
    Cureus. 2025;17:e96583.
    PubMed    
    Abstract available
    
    

84. CHUAH KH, Loo QY, Loh AJC, Leong JY, et al
    Editorial: Efficacy of Pharmacological Compared With Dietary Therapy for Patients With Irritable Bowel Syndrome-It Is Nice to Have a Choice. Authors' Reply.
    Aliment Pharmacol Ther. 2025 Nov 24. doi: 10.1111/apt.70469.
    PubMed    
    
    
    

85. HALMOS EP, Gibson PR
    Editorial: Efficacy of Pharmacological Compared With Dietary Therapy for Patients With Irritable Bowel Syndrome-It Is Nice to Have a Choice.
    Aliment Pharmacol Ther. 2025 Nov 24. doi: 10.1111/apt.70452.
    PubMed    
    
    
    

86. AREF A, Aldemerdash MA, Mohamed I, Abdallfatah A, et al
    Efficacy and safety of tenapanor in the management of irritable bowel syndrome with constipation: a systematic review and meta-analysis.
    Eur J Gastroenterol Hepatol. 2025 Nov 26. doi: 10.1097/MEG.0000000000003107.
    PubMed    
    Abstract available
    
    

87. LIN S, Shen P, Wan Y, Wang C, et al
    Methodological Comments on "Efficacy of ACupuncTure in Irritable bOwel syNdrome (ACTION)" Study.
    Gastroenterology. 2025 Dec 4:S0016-5085(25)06592.
    PubMed    
    
    
    

88. ZHANG M
    Comment on "Efficacy of ACupuncTure in Irritable bOwel syNdrome (ACTION): A Multicenter Randomized Controlled Trial".
    Gastroenterology. 2025 Dec 4:S0016-5085(25)06593.
    PubMed    
    
    
    

89. WANG ZZ, Chen YK, Li X, Lin L, et al
    Altered molecular signature of the intestinal microbiota in irritable bowel syndrome patients versus healthy controls: An updated systematic review.
    Indian J Gastroenterol. 2025 Dec 18. doi: 10.1007/s12664-025-01845.
    PubMed    
    Abstract available
    
    

90. KRAKOVSKI M, Madigan K, Cecil A, White B, et al
    Patient Factors Contributing to Wireless pH Monitoring Intolerance.
    J Clin Gastroenterol. 2025 Dec 12. doi: 10.1097/MCG.0000000000002272.
    PubMed    
    Abstract available
    
    

91. SIMADIBRATA DM, Koo TH, Utari AP, Ayad M, et al
    Rome III Versus Rome IV Criteria for Diagnosing Irritable Bowel Syndrome in a Southeast Asian Population: Insights From the Rome Foundation Global Epidemiology Study Household Survey.
    J Gastroenterol Hepatol. 2025 Dec 4. doi: 10.1111/jgh.70174.
    PubMed    
    Abstract available